BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND JAK3, L-JAK, 3718, ENSG00000105639, P52333, JAKL, JAK-3, LJAK, JAK3_HUMAN
11 results:

  • 1. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets.
    Cui Y; Han L; Shang J; Fang W; Zhao M; Chen D; Liu H
    Hum Pathol; 2022 May; 123():113-122. PubMed ID: 35181378
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Curcumin Analogue L48H37 Suppresses Human Osteosarcoma U2OS and MG-63 Cells' Migration and Invasion in Culture by Inhibition of uPA via the JAK/STAT Signaling Pathway.
    Lu KH; Wu HH; Lin RC; Lin YC; Lu PW; Yang SF; Yang JS
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374783
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Potential pitfalls of mass spectrometry to uncover mutations in childhood soft tissue sarcoma: A report from the Children's Oncology Group.
    Xu L; Wilson RA; Laetsch TW; Oliver D; Spunt SL; Hawkins DS; Skapek SX
    Sci Rep; 2016 Sep; 6():33429. PubMed ID: 27642091
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases.
    Terra SB; Jang JS; Bi L; Kipp BR; Jen J; Yi ES; Boland JM
    Mod Pathol; 2016 Aug; 29(8):824-31. PubMed ID: 27174587
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
    Liu X; Mody K; de Abreu FB; Pipas JM; Peterson JD; Gallagher TL; Suriawinata AA; Ripple GH; Hourdequin KC; Smith KD; Barth RJ; Colacchio TA; Tsapakos MJ; Zaki BI; Gardner TB; Gordon SR; Amos CI; Wells WA; Tsongalis GJ
    Clin Chem; 2014 Jul; 60(7):1004-11. PubMed ID: 24821835
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Hybrid liposomes inhibit the growth of primary effusion lymphoma in vitro and in vivo.
    Towata T; Komizu Y; Suzu S; Matsumoto Y; Ueoka R; Okada S
    Leuk Res; 2010 Jul; 34(7):906-11. PubMed ID: 20074798
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130.
    Hilkens CM; Is'harc H; Lillemeier BF; Strobl B; Bates PA; Behrmann I; Kerr IM
    FEBS Lett; 2001 Sep; 505(1):87-91. PubMed ID: 11557047
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis.
    Bauer JH; Liu KD; You Y; Lai SY; Goldsmith MA
    J Biol Chem; 1998 Apr; 273(15):9255-60. PubMed ID: 9535918
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Janus kinases in interleukin-2-mediated signaling: JAK1 and jak3 are differentially regulated by tyrosine phosphorylation.
    Liu KD; Gaffen SL; Goldsmith MA; Greene WC
    Curr Biol; 1997 Nov; 7(11):817-26. PubMed ID: 9382798
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The IL-4-induced tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK1 expression in human fibrosarcoma cells.
    Wang HY; Zamorano J; Yoerkie JL; Paul WE; Keegan AD
    J Immunol; 1997 Feb; 158(3):1037-40. PubMed ID: 9013940
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.
    Demoulin JB; Uyttenhove C; Van Roost E; DeLestré B; Donckers D; Van Snick J; Renauld JC
    Mol Cell Biol; 1996 Sep; 16(9):4710-6. PubMed ID: 8756628
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.